Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
diphtheria and tetanus toxoids and inactivated poliomyelitis vaccine
- Development stage
- Approved
- Lead developer
- GSK
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
Diphtheria and tetanus toxoids and inactivated poliomyelitis vaccine is a combination immunizing agent used to prevent illness caused by diphtheria, tetanus (lockjaw), and poliovirus. It is an inactivated (non-live) vaccine that works by stimulating the immune system to produce antibodies against these pathogens, thereby providing protection if exposed in the future. The primary indication is for immunization against diphtheria, tetanus, and polio—serious diseases that can cause severe complications or death. This combination may be used for both primary immunization series as well as booster doses, typically administered intramuscularly[1][5][6]. The product is available under several brand names including Kinrix, Quadracel, and Td Polio Adsorbed.
- Brand names
- KinrixQuadracelTd Polio Adsorbed
- Other names
- DT-PolioDTaP/polio vaccinediphtheria-tetanus-polio vaccineTd POLIO ADSORBED
02
Targets
Diphtheria toxin
Beyond the preview
Go deeper on diphtheria and tetanus toxoids and inactivated poliomyelitis vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on diphtheria and tetanus toxoids and inactivated poliomyelitis vaccine.